CK - Overview: Creatine Kinase (CK), Serum
Diagnosing and monitoring myopathies or other trauma, toxin, or drug-induced muscle injury
CNSA - Overview: Central Nervous System Consultation, Autopsy, Varies
Evaluation of congenital neurological disease Evaluation of neurodegenerative disease Evaluation of cases with a complex neurological or neurosurgical history Evaluation of sudden unexplained death This test is not intended for...
PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...
CEA - Overview: Carcinoembryonic Antigen (CEA), Serum
Monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma May be useful in assessing the effectiveness of chemotherapy or radiation treatment This test is not useful for screening the general population...
CALNN - Overview: Calretinin Immunostain, Technical Component Only
Separating mesotheliomas from carcinomas which usually lack expression of calretinin
CD22I - Overview: CD22 Immunostain, Technical Component Only
Determining B-cell lineage
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
ETGS - Overview: Ethyl Glucuronide Screen, Random, Urine
Screening for drug abuse involving alcohol
HPL - Overview: Human Placental Lactogen Immunostain, Technical Component Only
Aids in the identification of placenta-related tumors
LY27B - Overview: HLA-B27, Blood
Assisting in the diagnostic process of ankylosing spondylitis, juvenile rheumatoid arthritis, and reactive arthritis
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....